In this article, we review the recent progress in the combinative study of the NHSs from both the experimental and theoretical perspectives in terms of the growth mechanisms down to the atomic ...

Preclinical drug testing for clinical trial planning of novel combinative therapy with PI3K and MAPK inhibitors in colorectal cancer (CRC).

The past few decades have seen a substantial increase in the research based on nanocarrier based combinative drug therapies in various diseases such as cancer, tuberculosis, Alzheimer’s and, asthma.